10 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine]
- RxCUI
- 1724796
- RxNorm name
- 10 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine]
- Display name
- MARCAINE (Injectable)
- Full name
- 10 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine]
- Term type
- SBD
- Status
- Active
- Strength
- 7.5 mg/ml
- Dose form
- Injection 10 ml
- Route
- Injectable
- Updated
- 2026-10-27 17:49:05
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 012016
- Active start
- 012016
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| bupivacaine hydrochloride | 7.5 MG / 1 ML | bupivacaine | bupivacaine hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| bupivacaine | 1815 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | 10 ML Marcaine 7.5 MG/ML Injection | 1 | NAMES |
| RxNorm Name | 10 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine] | 1 | NAMES |
| RxNorm Synonym | 3 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 67578b56-7540-487e-1fba-481255620e78 | 1 | CODES |
| RxCUI | 1724796 | 1 | CODES |
| MMSL_CODE | MTH_RXN_BD14936 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 67578b56-7540-487e-1fba-481255620e78 | Marcaine 0.75 % in 10 ML Injection [PSN] · 10 ML bupivacaine hydrochloride 7.5 MG/ML Injection [Marcaine] [SBD] · 10 ML Marcaine 7.5 MG/ML Injection [SY] · Marcaine 0.75 % in 10 ML Injection [SY] · Marcaine 75 MG per 10 ML Injection [SY] | 5 | 38 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | 20260529 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20261023 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20261014 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260529 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260423 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20251106 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20250828 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20250825 |
| d75db1c5-e4eb-4583-b73d-3304c77abb50 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N01BB | Amides | ATC1-4 | bupivacaine | |
| FDASPL | D000577 | Amides | CHEM | has_chemical_structure | bupivacaine |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | bupivacaine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine hydrochloride |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine hydrochloride |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 7.5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | QUANTITY | 10 ML |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA016964 |
| NAMES | Prescribable Synonym | Marcaine 0.75 % in 10 ML Injection |
| NAMES | Tallman Synonym | 10 ML BUPivacaine hydrochloride 7.5 MG/ML Injection [Marcaine] |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |